| Literature DB >> 35539448 |
Ali Shoaib1,2, Muhammad Waqas1, Asem Elabasy1,2, Xinlai Cheng1, Qianqian Zhang1, Zuhua Shi1.
Abstract
Colloidal delivery systems have been widely used as carriers for controlled delivery of pesticides to improve the efficacy and photostability of natural and semi-synthetic pesticides. In this study, we have synthesized emamectin benzoate nanoformulations (EB + NFs) depending on polymeric nanocapsules (PNC) and two types of the nanosilica, mesoporous nanosilica (MCM-48) and silicon dioxide nanoparticles (SNPs) as carriers for the emamectin benzoate (EB). The fabricated nanoformulations were characterized by using X-ray diffraction analysis, Fourier transform infrared spectroscopy, particle size, zeta potential, morphology, absolute recovery (AR), entrapment efficiency (EE), UV stability and release kinetics. The obtained results showed that the carriers had a remarkable loading ability for EB and improved the EB photostability. The EE% of nanoformulations were 92.84%, 87.45% and 71.19% for emamectin benzoate polymeric nanocapsules (EB + PNC), emamectin benzoate SNPs (EB + SNPs) and emamectin benzoate MCM-48 (EB + MCM-48) respectively. The insecticidal activity of EB + NFs against Plutella xylostella showed that the EB + SNPs was more effective than other EB + NFs and EB alone. The LC50 values were 0.18, 4.03, 8.49 and 11.06 mg L-1 for EB + SNPs, EB + MCM-48, EB + PNC and EB respectively. The obtained results suggest the colloidal delivery systems that used in this study could improve the efficacy and photostability for EB, and they are able to overcome the disadvantage of the natural and semi-synthetic pesticides such as environmental sensitivity and to increase the efficacy of pesticides, which eventually leads to reduce the dosage of pesticides needed, reducing the number of applications required in comparison to conventional formulations. This journal is © The Royal Society of Chemistry.Entities:
Year: 2018 PMID: 35539448 PMCID: PMC9080111 DOI: 10.1039/c8ra01913d
Source DB: PubMed Journal: RSC Adv ISSN: 2046-2069 Impact factor: 4.036
Fig. 1Standard curve of emamectin benzoate.
Characterization of EB + NFs
| Formulation | Absolute recovery AR (%) | Entrapment efficiency EE (%) | Particle size (nm) ± SD | Zeta potential (mV) ± SD |
|---|---|---|---|---|
| EB + PNC | 72.51 | 92.84 | 219.93 ± 3.89 | −26.43 ± 2.90 |
| EB + SNPs | 94.55 | 87.45 | 142.77 ± 3.43 | −41.00 ± 1.31 |
| EB + MCM-48 | 74.29 | 71.19 | 119.73 ± 20.28 | −36.50 ± 0.56 |
Fig. 2TEM (left) and SEM (right) image of EB + PNC.
Analysis of variance of the main parameters and their interactions
| Source | EB | EB + PNC | EB + SNPs | EB + MCM-48 | ||||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
| |
| Time | 259.62 | 0.0001 | 428.39 | 0.0001 | 288.55 | 0.0001 | 77.57 | 0.0001 |
| Conc. | 392.98 | 0.0001 | 580.83 | 0.0001 | 1776.89 | 0.0001 | 221.82 | 0.0001 |
| Time* conc. | 21.12 | 0.0001 | 32.36 | 0.0001 | 20.07 | 0.0001 | 4.8 | 0.0001 |
Fig. 3TEM image of SNPs.
Fig. 4TEM image of EB + SNPs.
Fig. 5TEM image of MCM-48.
Fig. 6SEM image of EB + MCM-48.
Fig. 7XRD pattern of SNPs and MCM-48 nanosilica.
Fig. 8FTIR spectrum of SNPs and EB + SNPs.
Fig. 9FTIR spectrum of MCM-48 and EB + MCM-48.
Fig. 10Stability of the resulting EB + NFs and the active ingredient against UV radiation.
Fig. 11The release behaviors of the EB and EB + NFs.
Mortality (mean ± SD) of the third instar larvae of P. xylostella after EB + NFs exposure via leaf dippinga
| Formulation | Concentration (mg L−1) | Hours after treatment | ||
|---|---|---|---|---|
| 24 h | 48 h | 72 h | ||
| EB + SNPs | 0.1 | 14.77 ± 1.92 e | 27.27 ± 1.92 e | 34.09 ± 1.92 c |
| 0.2 | 31.81 ± 3.33 d | 52.27 ± 3.33 d | 65.91 ± 3.33 b | |
| 0.4 | 62.43 ± 3.33 c | 79.54 ± 3.33 c | 100.00 ± 0.00 a | |
| 0.8 | 76.14 ± 3.33 b | 86.36 ± 3.33 b | 100.00 ± 0.00 a | |
| 1.6 | 86.36 ± 3.33 a | 100.00 ± 0.00 a | 100.00 ± 0.00 a | |
| Control | 0.00 ± 0.00 f | 0.00 ± 0.00 f | 0.00 ± 0.00 d | |
| EB + MCM-48 | 0.5 | 10.00 ± 1.92 d | 13.33 ± 3.33 d | 22.22 ± 5.09 e |
| 1 | 14.44 ± 1.92 cd | 21.11 ± 3.85 cd | 38.89 ± 5.09 d | |
| 2 | 21.11 ± 5.09 c | 26.67 ± 6.67 c | 47.78 ± 5.09 c | |
| 4 | 37.78 ± 5.09 b | 45.56 ± 3.85 b | 64.44 ± 6.94 b | |
| 8 | 53.33 ± 8.82 a | 72.22 ± 10.18 a | 86.67 ± 3.33 a | |
| Control | 0.00 ± 0.00 e | 0.00 ± 0.00 e | 0.00 ± 0.00 f | |
| EB + PNC | 1 | 4.44 ± 0.00 cd | 11.11 ± 3.33 d | 17.77 ± 3.33 d |
| 2 | 5.56 ± 1.92 c | 14.44 ± 1.92 d | 26.67 ± 1.92 d | |
| 4 | 8.89 ± 1.92 c | 25.55 ± 3.33 c | 41.11 ± 3.33 c | |
| 8 | 17.78 ± 1.92 b | 43.33 ± 1.92 b | 60 ± 3.85 b | |
| 16 | 37.78 ± 3.85 a | 73.33 ± 3.85 a | 88.86 ± 3.83 a | |
| Control | 0.00 ± 0.00 e | 0.00 ± 0.00 e | 0.00 ± 0.00 e | |
| EB | 1 | 5.56 ± 1.92 de | 11.11 ± 1.92 d | 16.67 ± 3.33 e |
| 2 | 8.89 ± 3.85 cd | 14.44 ± 1.92 d | 24.44 ± 1.92 d | |
| 4 | 13.33 ± 3.33 c | 23.33 ± 3.85 c | 51.11 ± 3.85 c | |
| 8 | 24.44 ± 1.92 b | 41.11 ± 1.92 b | 67.78 ± 5.09 b | |
| 16 | 42.22 ± 3.85 a | 62.22 ± 5.09 a | 84.44 ± 5.09 a | |
| Control | 0.00 ± 0.00 e | 0.00 ± 0.00 e | 0.00 ± 0.00 f | |
Different letter in column under same formulation followed after mean (±SD) indicate significant difference at P = 0.05 level.
LC50–90 values of EB + NFs against the third instar larvae of P. xylostellaa
| Formulation | Time (h) | LC50 (mg L−1) (LCL–UCL) | LC90 (mg L−1) (LCL–UCL) | Slope ± SE |
|
|---|---|---|---|---|---|
| EB + SNPs | 24 | 0.32 (0.27–0.37) | 1.67 (1.26–2.47) | 1.78 ± 0.16 | 2.66 |
| 48 | 0.18 (0.15–0.21) | 0.75 (0.60–0.99) | 2.07 ± 0.19 | 3.47 | |
| EB + MCM-48 | 24 | 7.44 (5.37–12.24) | 89.03 (40.26–347.38) | 1.18 ± 0.16 | 1.23 |
| 48 | 4.03 (3.23–5.34) | 33.81 (19.96–76.32) | 1.38 ± 0.16 | 5.05 | |
| 72 | 1.80 (1.46–2.21) | 14.27 (9.61–25.64) | 1.42 ± 0.15 | 3.32 | |
| EB + PNC | 24 | 34.79 (21.51–82.29) | 359.51 (131.92–2392.08) | 1.26 ± 0.22 | 3.23 |
| 48 | 8.49 (7.00–10.74) | 55.23 (35.88–103.62) | 1.57 ± 0.16 | 3.82 | |
| 72 | 4.52 (3.83–5.37) | 26.30 (19.05–41.02) | 1.67 ± 0.15 | 7.45 | |
| EB | 24 | 24.83 (17.41–56.21) | 311.32 (119.88–1783.47) | 1.20 ± 0.18 | 1.32 |
| 48 | 11.06 (8.56–15.75) | 99.64 (53.95–265.99) | 1.34 ± 0.16 | 2.70 | |
| 72 | 4.22 (3.55–5.04) | 24.14 (17.46–38.08) | 1.69 ± 0.16 | 1.70 |
LCL: lower confidence limit and ULC: upper confidence limit.